Nantong JiangTian Chemical Co., Ltd. (SHE:300927)
China · Delayed Price · Currency is CNY 31.82
-2.14 (-6.30%)
At close: Feb 13, 2026
SHE:300927 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,273 | 685.41 | 707.26 | 734.24 | 707.98 | 436.51 |
Other Revenue | 2.97 | 2.97 | 1.86 | 3.06 | 2 | 1.19 |
| 1,276 | 688.38 | 709.12 | 737.29 | 709.97 | 437.71 | |
Revenue Growth (YoY) | 81.92% | -2.93% | -3.82% | 3.85% | 62.20% | -12.46% |
Cost of Revenue | 1,181 | 582.35 | 569.15 | 605.2 | 568.03 | 331.84 |
Gross Profit | 94.45 | 106.03 | 139.97 | 132.1 | 141.94 | 105.86 |
Selling, General & Admin | 62.04 | 45.42 | 42.02 | 42.05 | 40.55 | 30.08 |
Research & Development | 8.63 | 5.08 | 8 | 6.39 | 6.86 | 7.04 |
Other Operating Expenses | 3.1 | 3.76 | 5.01 | 3.79 | 3.65 | 2.64 |
Operating Expenses | 73.46 | 54.45 | 54.88 | 52.25 | 51.22 | 40.49 |
Operating Income | 20.99 | 51.59 | 85.09 | 79.85 | 90.72 | 65.37 |
Interest Expense | -1.38 | -1.81 | -3.08 | -3.75 | -2.76 | -1.36 |
Interest & Investment Income | 2.91 | 6.27 | 5.27 | 4.72 | 1.69 | 0.34 |
Currency Exchange Gain (Loss) | 0.19 | 0.19 | 1.68 | 1.28 | -1.12 | -0.73 |
Other Non Operating Income (Expenses) | 1.04 | -0.37 | -0.53 | -0.14 | -2.43 | 0.55 |
EBT Excluding Unusual Items | 23.75 | 55.87 | 88.42 | 81.96 | 86.1 | 64.17 |
Gain (Loss) on Sale of Investments | -0.13 | -0.05 | -0.04 | 0.02 | 0.01 | - |
Gain (Loss) on Sale of Assets | - | - | 0.01 | - | - | 0.03 |
Asset Writedown | -0.78 | -0 | -0.03 | -0.03 | -0.22 | - |
Other Unusual Items | 256 | 255.29 | 0.98 | 0.62 | 2.24 | - |
Pretax Income | 278.84 | 311.11 | 89.34 | 82.57 | 88.12 | 64.2 |
Income Tax Expense | 6.88 | 13.37 | 20.79 | 18.77 | 12.3 | 9.2 |
Net Income | 271.96 | 297.74 | 68.55 | 63.79 | 75.83 | 55.01 |
Net Income to Common | 271.96 | 297.74 | 68.55 | 63.79 | 75.83 | 55.01 |
Net Income Growth | 459.78% | 334.35% | 7.45% | -15.87% | 37.85% | 2.36% |
Shares Outstanding (Basic) | 144 | 144 | 144 | 144 | 144 | 108 |
Shares Outstanding (Diluted) | 144 | 144 | 144 | 144 | 144 | 108 |
Shares Change (YoY) | -0.06% | -0.01% | 0.00% | 0.01% | 33.34% | -0.02% |
EPS (Basic) | 1.88 | 2.06 | 0.47 | 0.44 | 0.53 | 0.51 |
EPS (Diluted) | 1.88 | 2.06 | 0.47 | 0.44 | 0.53 | 0.51 |
EPS Growth | 460.10% | 334.39% | 7.45% | -15.88% | 3.38% | 2.38% |
Free Cash Flow | -166.58 | -250.55 | -39.94 | 64.34 | 31.78 | -26.48 |
Free Cash Flow Per Share | -1.15 | -1.74 | -0.28 | 0.45 | 0.22 | -0.24 |
Dividend Per Share | 0.090 | 0.090 | 0.145 | 0.135 | 0.160 | 0.117 |
Dividend Growth | -37.93% | -37.93% | 7.41% | -15.63% | 37.10% | -4.50% |
Gross Margin | 7.40% | 15.40% | 19.74% | 17.92% | 19.99% | 24.19% |
Operating Margin | 1.65% | 7.49% | 12.00% | 10.83% | 12.78% | 14.94% |
Profit Margin | 21.32% | 43.25% | 9.67% | 8.65% | 10.68% | 12.57% |
Free Cash Flow Margin | -13.06% | -36.40% | -5.63% | 8.73% | 4.48% | -6.05% |
EBITDA | 51.29 | 84.84 | 122.28 | 114.23 | 124.76 | 82.44 |
EBITDA Margin | 4.02% | 12.32% | 17.24% | 15.49% | 17.57% | 18.84% |
D&A For EBITDA | 30.3 | 33.25 | 37.19 | 34.38 | 34.04 | 17.07 |
EBIT | 20.99 | 51.59 | 85.09 | 79.85 | 90.72 | 65.37 |
EBIT Margin | 1.65% | 7.49% | 12.00% | 10.83% | 12.78% | 14.94% |
Effective Tax Rate | 2.47% | 4.30% | 23.27% | 22.74% | 13.95% | 14.33% |
Revenue as Reported | 1,276 | 688.38 | 709.12 | 737.29 | 709.97 | 437.71 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.